CSL Limited (ASX: CSL)
Sector: Health Care
Market cap: A$96.3B (as of 2 Nov 2026)
Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
Data as of 2 Nov 2026.
Recent capital raises
| Date | Type | Amount | Price | Discount | Source |
|---|---|---|---|---|---|
| 13 Feb 2022 | SPP | $750M | $253.57 | 2% discount | Filing ↗ |
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 4 Sept 2026 | The Vanguard Group (The Vanguard Group, Inc. and its controlled entities including those listed in Annexure A) | Increase | 6.0% → 7.001% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 1 June 2026 | Ms Carolyn Hewson AO | Bought 1,036 Ordinary Shares | Filing ↗ |
| 26 May 2026 | Gordon Naylor | Bought 1,100 Ordinary Shares | Filing ↗ |
| 15 May 2026 | Ms Alison Watkins AM | Bought 2540 Ordinary Shares | Filing ↗ |
| 18 Nov 2025 | Mr Brian Daniels | Bought 1,700 ADRs | Filing ↗ |
| 17 Mar 2025 | Dr Megan Elizabeth CLARK | Bought 200 Ordinary Shares | Filing ↗ |
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 28 Oct 2025 | FY26 | Given these factors affecting our performance in the first half of the year, we are revising our Financial Year 2026 revenue growth outlook to 2-3%, down from 4-5%, and updated NPATA growth to 4-7%, reduced from +7-10% at constant currency. | Filing ↗ |
Ask about CSL in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has CSL raised money in the last year, and at what discount?
- What was CSL's latest cash position and runway?
Loading CSL…